Finance

Roʻyxatlar
SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
7,08 US$
0,00%
(0,00) 1K
1-okt, 14:50:24 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
SHPMY tikeri uchun statistika yaratilmoqda...
Bozor kapitali
65,60 mlrd
Oʻrtacha hajm
116,00
Hajmi
0,00
52 haftalik eng yuqori
8,23 US$
52 haftalik eng past
6,41 US$
Beta
0,58
Muomaladagi aksiyalar
183,81 mln
Xodimlar soni
49 ming
Bozor kapitali
65,60 mlrd
Oʻrtacha hajm
116,00
Hajmi
0,00
52 haftalik eng yuqori
8,23 US$
52 haftalik eng past
6,41 US$
Beta
0,58
Muomaladagi aksiyalar
183,81 mln
Xodimlar soni
49 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Shanghai Pharmaceuticals Holdings ADR haqida
CEO-
Xodimlar soni48,6 ming
Asos solingan18-yan, 1994
Bosh ofislar-
SektorHealth care provider
Veb-saytsphchina.com
Avvalgi hisobotlarBarcha qiymatlar – CNY
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – CNY
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
73,48 mlrd
68,51 mlrd
75,26 mlrd
72,21 mlrd
Sotilgan mahsulotning tannarxi
66,03 mlrd
60,55 mlrd
67,17 mlrd
64,09 mlrd
Daromad narxi
66,03 mlrd
60,55 mlrd
67,17 mlrd
64,09 mlrd
Tadqiqot va ishlanmalarga xarajatlar
556,53 mln
824,53 mln
468,22 mln
502,64 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
4,70 mlrd
4,97 mlrd
4,59 mlrd
4,65 mlrd
Operatsion xarajatlar
5,58 mlrd
5,91 mlrd
5,47 mlrd
5,55 mlrd
Jami operatsion xarajatlar
71,60 mlrd
66,47 mlrd
72,63 mlrd
69,64 mlrd
Operatsion daromad
1,88 mlrd
2,04 mlrd
2,63 mlrd
2,57 mlrd
Boshqa nooperatsion daromad
-84,84 mln
-63,65 mln
-47,88 mln
-7,43 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
1,48 mlrd
1,52 mlrd
2,42 mlrd
3,21 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
1,61 mlrd
1,44 mlrd
2,27 mlrd
3,03 mlrd
Daromad soligʻi boʻyicha xarajat
485,91 mln
534,14 mln
569,09 mln
720,64 mln
Amaldagi soliq stavkasi
32,89%
35,10%
23,52%
22,43%
Boshqa operatsion xarajatlar
129,62 mln
271,29 mln
132,16 mln
186,62 mln
Sof foyda
688,20 mln
577,49 mln
1,42 mlrd
2,09 mlrd
Sof foyda marjasi
0,94%
0,84%
1,88%
2,89%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
206,57 mln
-
38,70 mln
873,52 mln
Foizlarni toʻlash xarajatlari
-393,02 mln
-470,36 mln
-347,64 mln
-358,39 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-186,45 mln
-470,36 mln
-308,94 mln
515,13 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
2,26 mlrd
2,54 mlrd
3,12 mlrd
3,07 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
39,99 mln
-157,15 mln
-
-179,70 mln
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari